Results 131 to 140 of about 24,826 (263)
Platelet-activating factor (PAF) acetylhydrolase exhibits a Ca(2+)-independent phospholipase A(2) activity and degrades PAF as well as oxidized phospholipids (oxPL). Such phospholipids are accumulated in the artery wall and may play key roles in vascular
Tselepis, A. D., Tellis, C. C.
core
Inonotus obliquus mitigates obesity through the targeted enrichment of intestinal Enterococcus casseliflavus (EC). EC facilitates thermogenesis in adipose tissues, augments energy expenditure, enhances systemic metabolic homeostasis, and diminishes low‐grade inflammation.
Xiao Sun +8 more
wiley +1 more source
Lipoprotein(a) as a Risk Factor for Myocardial Infarction, Cardiovascular, and All-Cause Mortality in Patients with Type 2 Diabetes Mellitus. [PDF]
Čuješ J +3 more
europepmc +1 more source
Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?
ABSTRACT Prostate cancer (PCa) is the second most frequently diagnosed cancer in men worldwide and the fifth leading cause of cancer‐related mortality, presenting urgent unmet clinical needs in diagnosis and treatment. The recognition of the microbiome as a key factor in human health has prompted numerous studies, revealing an exciting new approach to ...
Lara R. S. Fonseca +6 more
wiley +1 more source
Tea consumption and major adverse cardiovascular events in coronary heart disease: a non-linear dose-response analysis with joint effect modification by lipoprotein(a) and systemic inflammation - a UK Biobank study. [PDF]
Zhang C.
europepmc +1 more source
This review systematically elucidates the multifactorial anti‐aging mechanisms of extracellular vesicles (EVs). By bridging fundamental biology with advanced bioengineering, scalable manufacturing, and clinical translation, it establishes a comprehensive framework for developing next‐generation EVs‐based precision nanotherapeutics to combat systemic ...
Xian Huang +6 more
wiley +1 more source
Tracking Lipoprotein(a) Risk Through Inflammatory Biomarkers. [PDF]
Cheng CY, Liu PY.
europepmc +1 more source
ABSTRACT The effects of obesity on the vasculature and perivascular adipose tissue (PVAT) function vary according to the vascular territory. Nebivolol is a third‐generation β‐blocker that exerts vasculoprotective effects in obesity. The thoracic and abdominal aorta show different responses under physiological conditions, and their PVATs have a ...
Thales M. H. Dourado +5 more
wiley +1 more source
Lipoprotein(a), Coronary Complexity, and Stent-Related Outcomes: Meta-Analytic Insights for the Interventional Cardiologist. [PDF]
Cereda A +9 more
europepmc +1 more source
ABSTRACT In a scenario with increasing cases of obesity and diabetes worldwide, branched‐chain amino acids (BCAA) metabolism has become an important factor in the understanding of these pathologies. More recently, its chronic high plasma levels have been postulated, alongside glucose, inflammatory factors, and other molecules, as an important ...
Bernardo Starling‐Soares +4 more
wiley +1 more source

